Search research articles
Contact Us
Filters
Showing results (21-30 of 31) with videos related to
Page
of 4
Sort By:
The Canadian Journal of Urology
|
April 19, 2021
Focal bladder neck cautery associated with low rate of post-Aquablation bleeding
Dean S Elterman, Susan Foller, Burkhard Ubrig, et al.
Cancers
|
September 14, 2024
Cabozantinib Plus Nivolumab in Adult Patients with Advanced or Metastatic Renal Cell Carcinoma: A Retrospective, Non-Interventional Study in a Real-World Cohort/GUARDIANS Project
Thomas Hilser, Christopher Darr, Günter Niegisch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 11, 2022
Tailored Immunotherapy Approach With Nivolumab in Advanced Transitional Cell Carcinoma
Marc-Oliver Grimm, Bernd Jürgen Schmitz-Dräger, Uwe Zimmermann, et al.
Journal of Clinical Medicine
|
December 30, 2025
Prostate Artery Embolization vs. Holmium Laser Enucleation of the Prostate: A Matched Pair Analysis of Functional Outcomes and Complications
Simon Hannes Friedrich Leschik, Robert Große Siemer, Friedrich-Carl von Rundstedt, et al.
Aktuelle Urologie
|
April 6, 2021
Marius Butea-Bocu, Susan Foller, Jochen Gleisner, et al.
European Urology Open Science
|
August 23, 2024
Radical Prostatectomy in Kidney Transplant Recipients-A Multicenter Experience
Jacob Schmidt, Abdulbaki Yakac, Robert Peters, et al.
The Lancet. Oncology
|
March 3, 2023
Tailored immunotherapy approach with nivolumab with or without ipilimumab in patients with advanced transitional cell carcinoma after platinum-based chemotherapy (TITAN-TCC): a multicentre, single-arm, phase 2 trial
Marc-Oliver Grimm, Christine Barbara Grün, Günter Niegisch, et al.
Procare : Das Forbildungsmagazin Fur Pflegeberufe
|
September 26, 2022
Andreas Manseck, Alexander Piotrowski, Marius Butea-Bocu, et al.
The Lancet. Oncology
|
October 16, 2023
Tailored immunotherapy approach with nivolumab with or without nivolumab plus ipilimumab as immunotherapeutic boost in patients with metastatic renal cell carcinoma (TITAN-RCC): a multicentre, single-arm, phase 2 trial
Marc-Oliver Grimm, Emilio Esteban, Philippe Barthélémy, et al.
JAMA Oncology
|
May 9, 2024
Nivolumab + Ipilimumab as Immunotherapeutic Boost in Metastatic Urothelial Carcinoma: A Nonrandomized Clinical Trial
Marc-Oliver Grimm, Martin Schostak, Christine Barbara Grün, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 31) with videos related to
Sort By:
Page
of 4
The Canadian Journal of Urology
|
April 19, 2021
Focal bladder neck cautery associated with low rate of post-Aquablation bleeding
Dean S Elterman, Susan Foller, Burkhard Ubrig, et al.
Cancers
|
September 14, 2024
Cabozantinib Plus Nivolumab in Adult Patients with Advanced or Metastatic Renal Cell Carcinoma: A Retrospective, Non-Interventional Study in a Real-World Cohort/GUARDIANS Project
Thomas Hilser, Christopher Darr, Günter Niegisch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 11, 2022
Tailored Immunotherapy Approach With Nivolumab in Advanced Transitional Cell Carcinoma
Marc-Oliver Grimm, Bernd Jürgen Schmitz-Dräger, Uwe Zimmermann, et al.
Journal of Clinical Medicine
|
December 30, 2025
Prostate Artery Embolization vs. Holmium Laser Enucleation of the Prostate: A Matched Pair Analysis of Functional Outcomes and Complications
Simon Hannes Friedrich Leschik, Robert Große Siemer, Friedrich-Carl von Rundstedt, et al.
Aktuelle Urologie
|
April 6, 2021
Marius Butea-Bocu, Susan Foller, Jochen Gleisner, et al.
European Urology Open Science
|
August 23, 2024
Radical Prostatectomy in Kidney Transplant Recipients-A Multicenter Experience
Jacob Schmidt, Abdulbaki Yakac, Robert Peters, et al.
The Lancet. Oncology
|
March 3, 2023
Tailored immunotherapy approach with nivolumab with or without ipilimumab in patients with advanced transitional cell carcinoma after platinum-based chemotherapy (TITAN-TCC): a multicentre, single-arm, phase 2 trial
Marc-Oliver Grimm, Christine Barbara Grün, Günter Niegisch, et al.
Procare : Das Forbildungsmagazin Fur Pflegeberufe
|
September 26, 2022
Andreas Manseck, Alexander Piotrowski, Marius Butea-Bocu, et al.
The Lancet. Oncology
|
October 16, 2023
Tailored immunotherapy approach with nivolumab with or without nivolumab plus ipilimumab as immunotherapeutic boost in patients with metastatic renal cell carcinoma (TITAN-RCC): a multicentre, single-arm, phase 2 trial
Marc-Oliver Grimm, Emilio Esteban, Philippe Barthélémy, et al.
JAMA Oncology
|
May 9, 2024
Nivolumab + Ipilimumab as Immunotherapeutic Boost in Metastatic Urothelial Carcinoma: A Nonrandomized Clinical Trial
Marc-Oliver Grimm, Martin Schostak, Christine Barbara Grün, et al.
Page
of 4